Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
7 November 2016 |
Main ID: |
NCT00875147 |
Date of registration:
|
02/04/2009 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases
|
Scientific title:
|
Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases A Case Matched Control Study |
Date of first enrolment:
|
April 2009 |
Target sample size:
|
163 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT00875147 |
Study type:
|
Observational |
Study design:
|
Observational Model: Cohort, Time Perspective: Retrospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
France
|
Spain
|
Switzerland
| | | | | |
Contacts
|
Name:
|
Stefan Breitenstein, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Departement of Visceral and Transplantation Surgery of University hospital of Zurich |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with neoadjuvant chemotherapy prior to liver resection
Exclusion Criteria:
- Patients without neoadjuvant chemotherapy
Age minimum:
18 Years
Age maximum:
90 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Colorectal Liver Metastases
|
Intervention(s)
|
Drug: bevacizumab
|
Primary Outcome(s)
|
Overall complications
[Time Frame: postoperative]
|
Secondary Outcome(s)
|
specific complications such as liver insufficiency, length of hospital stay
[Time Frame: postoperative]
|
Secondary ID(s)
|
StV 12-2009
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|